ConductScience.org, home

Gene · 79813

NIH grants1,962

NIH grants whose papers are about the gene, through NIH's grant-paper links.

501 to 520 of 1,962

Download this page as JSON
GrantTitleEHMT1 papersNewest fiscal year
R01DK101426Elucidating the role of the FXR-PTEN-PI3K-AKT-mTOR axis in liver progenitor cell-driven liver regeneration12023
R01DK115703Origin of Excess Acid in Uric Acid Urolithiasis12023
R01GM036477Trans-Acting Factors Causing Cell-Specific Gene Control12023
R01GM056414Novel Agonists and Inverse Agonists for B-Family GPCRs12023
R01GM082856Function of MLL in transcription regulation12023
R01GM113033Collaboration of chromatin remodeling and signaling pathways in pluripotency12023
R01GM114141Mechanisms mediating immune response upon sensing of nuclear viral DNA12023
R01GM115882Structural and functional analysis of gene silencing12023
R01GM116897Suppression of duplication-mediated genome rearrangements by protein sumoylation12023
R01GM135421Histone Arginine Demethylation through Cleavage12023
R01HD097665Spreading of Xist RNA and Polycomb complexes along the inactive X-chromosome.12023
R01HD099638Anti-Coagulation Factors and Placentation12023
R01HD099975Molecular underpinnings of Prader-Willi syndrome12023
R01HL083359The Dynamics of Human Atrial Fibrillation12023
R01HL130046Augmentation of Tissue Perfusion with Ultrasound-mediated Cavitation12023
R01HL148110Biological Mechanisms through which TMAO Promotes Atherosclerosis12023
R03DK129627Mechanisms of ketosis and near-normoglycemia remission in obese African Americans with ketosis-prone diabetes12023
R21MH127485Neuronal Activity-dependent Pomoter Usage12023
R25GM055336UNC Initiative for Maximizing Student Development12023
R41DK133051Novel therapeutic intervention of early-stage T1D12023

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/79813/grants?page=26